Legal 500
  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • Article

    DOJ Announces Largest Medical Fraud Uncovered

    Yesterday, the Federal Bureau of Investigation and the Department of Justice uncovered the largest medical fraud in United States history, reporting nearly $15 billion in losses. Fifty federal districts participated in the investigation, which included 324 defendants, 96 medical professionals charged, and $245 million in seized assets
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    FDA Grants Extension For Certain Companies To Comply With DSCSA

    The Food and Drug Administration (FDA) announced on October 9, 2024, that it was issuing an exemption for certain companies to give them more time to comply with the requirements...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    FDA Sets Date For The Digital Health Advisory Committee Meeting To Discuss Generative Artificial Intelligence-Enabled Devices

    On November 20-21, 2024, FDA will be holding a Digital Health Advisory Committee Meeting to discuss total product lifecycle considerations for Generative Artificial Intelligence (AI)-enabled devices.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Healthcare Companies Cashing In On Financing Vehicle Boom

    John Washlick, shareholder in the firm's Healthcare section, is quoted in the Modern Healthcare article, "Healthcare companies cashing in on financing vehicle boom."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Increasing Scrutiny On CARES Act Compliance: What Healthcare Providers Can Do To Prepare

    ROBERT B. RAMSEY III JOHN P. CUNNINGHAM MICHELLE GARVEY BRENNFLECK HEATHER R. ALLEVA
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Misperceptions About Nicotine And Conventional Cigarettes Continue

    As reported in the Tobacco Reporter, a new survey, funded by Philip Morris International's U.S. affiliates (PMI U.S.), found that 47% of U.S. healthcare practitioners...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Portfolio Strategy: How To Drive Deal Value With Drug Target Analysis

    For life sciences companies and investors, determining the value of a single product or an entire product portfolio is a crucial first step in asset investment, acquisition, or divestiture.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    2024 Pre-Election Guide And Legislative Outlook

    The outcome of the 2024 general election will be closely watched on election night and in the days to follow as we await the confirmed results.
    United StatesGovernment, Public Sector
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Video

    Buchanan Government Relations Post-Election Webinars (Video)

    Buchanan's Government Relations team hosted two Post-Election webinars to discuss the results of the Federal, Pennsylvania and Florida midterm elections...
    United StatesGovernment, Public Sector
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    U.S. Terminates Arms Embargo On Ethiopia – Export Licenses No Longer Subject To Policy Of Denial

    The United States has lifted its arms embargo on Ethiopia, ending a policy that denied ITAR-controlled exports since 2021 due to human rights concerns and humanitarian crisis.
    United StatesGovernment, Public Sector
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Dominican Republic To Require Venezuelan Nationals To Apply For A Visa To Enter The Country

    The Dominican Republic's Ministry of Foreign Affairs announced that as of December 16, 2019, Venezuelan nationals wishing to enter the Dominican Republic will be required to obtain a visa to travel
    United StatesImmigration
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    H1B Cap – Eight Times As Many Filings As Available Numbers!

    On April 28, 2023, USCIS announced that for Fiscal Year 2024 (begins October 1, 2023), it received 758,994 eligible H1B registrations. This is an astonishing number compared to the 474,421...
    United StatesImmigration
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    September 2019 Visa Bulletin Update

    You may have seen articles discussing next month's "Visa Bulletin" and what it means for employment-based visa preference categories.
    United StatesImmigration
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Update On E And L Spouses – Employment Authorization

    Today U.S. Citizenship and Immigration Services (USCIS) issued an update regarding changes it is making to assist those spouses of E and L visa holders who are in the...
    United StatesImmigration
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Ethics For Intellectual Property Attorneys And Patent Agents (Video)

    Intellectual Property attorneys and staff are subject to special ethics rules in addition to traditional ethics rules governing the practice of law.
    United StatesIntellectual Property
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Federal Circuit Shifts Burdens For Motions To Amend

    On October 4, 2017, the Federal Circuit, sitting en banc, issued its long-awaited decision in Aqua Products, Inc. v. Matal. Appeal No. 2015-1177.
    United StatesIntellectual Property
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    On-Brand Strategies: Developing And Enforcing Distinctive Brands (Video)

    Strong brands are an essential component of any successful business. In today's crowded marketplace with consumers more distracted than ever by a constant stream of content...
    United StatesIntellectual Property
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Video

    Recap And Key Insights From Record Cases: Delaware 2023 Litigation (Video)

    In 2023, the Delaware courts made significant decisions implicating different areas of intellectual property (IP) and corporate law. These rulings addressed topics such as induced infringement...
    United StatesIntellectual Property
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    BIS Seeks Significant Funding Increase For FY 2027 Impacting Export Controls Enforcement And Section 232 Tariffs

    The Department of Commerce, Bureau of Industry and Security (BIS) submitted a budget request to Congress for Fiscal Year 2027 (FY27)...
    United StatesInternational Law
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Department Of Commerce Pauses Processing Of All New Export License Applications

    The Bureau of Industry and Security (BIS), the export licensing arm of the Department of Commerce, has reportedly paused processing of all new export license applications without explanation.
    United StatesInternational Law
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney

Showing 261–280 of 1803 results

PreviousNext
Legal Intelligence Newsletters